Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC (hPPL) for Steroid-Resistant Acute GVHD
NCT00827398Phase 2Completed
- Start
- Jan 2009
- Primary completion
- Jul 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in Acute Graft-Versus-Host Disease (aGvHD). Started Jan 2009; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT00827398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827398.